Open AccessA Case of Severe Rebound after Switching from Fingolimod to Ocrelizumab
Author(s) -
Alevtina Ersoy,
Ceyda Tanoğlu,
Hasan Yaşar,
Canan Duman İlki
Publication year - 2021
Publication title -
archives of basic and clinical research
Language(s) - English
Resource type - Journals
ISSN - 2687-4520
DOI - 10.5152/abcr.2021.20031
Subject(s) - ocrelizumab , fingolimod , medicine , dermatology , multiple sclerosis , psychiatry , rituximab , lymphoma